Your browser doesn't support javascript.
loading
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial.
Rosenstock, Julio; Emral, Rifat; Sauque-Reyna, Leobardo; Mohan, Viswanathan; Trescolí, Carlos; Al Sifri, Saud; Lalic, Nebojsa; Alvarez, Agustina; Picard, Pascaline; Bonnemaire, Mireille; Demil, Nacima; McCrimmon, Rory J.
Afiliación
  • Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, TX juliorosenstock@dallasdiabetes.com.
  • Emral R; Department of Endocrinology and Metabolic Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Sauque-Reyna L; Instituto de Diabetes Obesidad y Nutrición S.C., Cuernavaca, Morelos, Mexico.
  • Mohan V; Dr. Mohan's Diabetes Specialities Centre & Madras Diabetes Research Foundation, IDF Centre of Excellence in Diabetes Care & ICMR Centre for Advanced Research on Diabetes, Chennai, India.
  • Trescolí C; Hospital Universitario de La Ribera, Alzira, Spain.
  • Al Sifri S; Al Hada Military Hospital, Taif, Saudi Arabia.
  • Lalic N; Faculty of Medicine of the University of Belgrade, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Belgrade, Serbia.
  • Alvarez A; Sanofi, Buenos Aires, Argentina.
  • Picard P; IviData LIFE SCIENCES, Levallois-Perret, France.
  • Bonnemaire M; Sanofi, Paris, France.
  • Demil N; Diabetes Medical Operation Department, Sanofi, Chilly-Mazarin, France.
Diabetes Care ; 2021 Jun 28.
Article en En | MEDLINE | ID: mdl-34183429

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Diabetes Care Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Diabetes Care Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos